Predict your next investment

Venture Capital
3x5partners.com

See what CB Insights has to offer

Investments

13

Portfolio Exits

2

Funds

1

About 3x5 Partners

3x5 Partners is a growth-oriented venture capital firm that primarily invests in innovations in life sciences and resource-driven sectors.

3x5 Partners Headquarter Location

2540 NE Martin Luther King Jr Blvd

Portland, Oregon, 97212,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest 3x5 Partners News

Claros Technologies Closes $5 Million Series A Funding Round

Sep 1, 2021

Claros Technologies Closes $5 Million Series A Funding Round ST. PAUL, Minn. Aug 31, 2021 6:16 PM EDT ST. PAUL, Minn., Aug. 31, 2021 /PRNewswire/ -- Claros Technologies announced the closing of a $5 million Series A funding round led by Portland based 3x5 Partners. Claros was founded with the mission to solve problems without creating new ones with a focus on sustainability in everything they do. From the non-toxic antimicrobial and antiviral textiles that displace the current toxic silver and copper options, to the capture and detoxification of harmful chemicals, such as PFAS, in our environment, Claros is well positioned to make a difference and do so in a way that tangibly improves our world.   Claros Technologies  $5 million Series A funding led by Portland based 3x5 Partners. 3x5 Partner's Managing Director, Nicholas Walrod expressed that "we are ecstatic to be partnering with the Claros team. Instead of engaging in problem displacement, Claros is providing clear, complete solutions to identified and urgent needs with large market opportunities." 3x5 Partners strives to 'invest in what the world needs' by partnering with promising companies whose technology offer real solutions in the healthcare and climate sectors. The Series A capital raise will allow the team at Claros to expand the applications of their breakthrough technology at the scale required to address problems for which the world needs immediate solutions. By proving the ZioShield™ antiviral technology can be achieved at roll-to-roll manufacturing scale, the team is rapidly responding to the high demand for embedding antiviral technology in a whole new range of applications. In the large-scale water treatment sector, Claros is well positioned to quickly prove themselves as a market leader in PFAS remediation with their ability to both capture and detoxify the problematic fluorocarbons. CEO and Co-founder, Michelle Bellanca described that "Claros is doing something truly revolutionary to address the massive PFAS clean-up needs that are quickly coming down the regulatory pipeline. The demand for cost effective and scalable treatment options, that both capture and destroy these 'forever chemicals' is here, and Claros has developed the solution that the world needs right now." Clarosafe® removes both long and short chain PFAS chemicals from our ecosystem, compared to current treatment options that are limited to landfills and incineration, which only spread this problematic toxin further in our environment. "We are building a PFAS remediation ecosystem, where our partners can find accurate testing capabilities, efficient sorbents for PFAS removal, and sustainable disposal pathways that permanently remove PFAS from the environment" explained Co-founder Abdennour Abbas. About ClarosClaros Technologies Inc. is an advanced materials company that strives to lead the industry towards a holistic approach in materials design and innovation to enable the development of more efficient, safe, and sustainable products with zero toxic waste. Claros is able to utilize nanoparticle growth technology to substantially impact multiple significant markets, including the rapidly growing PFAS remediation market and the functional textiles space with their antiviral and antimicrobial ZioShield™ technology. About 3x5 PartnersWith over $400 million raised, 3x5 Partners is a venture capital firm that collaborates with passionate entrepreneurs to solve challenges in global health and climate solutions. Established in Portland, Oregon in 2011, 3x5 has delivered both top returns to investors and meaningful impact to the world. Claros Contact Info:Find out more at https://clarostechnologies.com For inquiries, reach Claros at contact@clarostech.com 3x5 Contact Info:More information is available at www.3x5partners.com  Contact: info@3x5partners.com View original content to download multimedia: https://www.prnewswire.com/news-releases/claros-technologies-closes-5-million-series-a-funding-round-301366707.html SOURCE Claros Technologies

3x5 Partners Investments

13 Investments

3x5 Partners has made 13 investments. Their latest investment was in Claros Technologies as part of their Series A on August 8, 2021.

CBI Logo

3x5 Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/3/2021

Series A

Claros Technologies

$5.35M

Yes

University of Minnesota Discovery Capital

11

4/27/2021

Series C

Arch Oncology

$105M

No

Adage Capital Management, Avego Healthcare Capital, Broadfin Capital, Cowen, Eventide Asset Management, FMB Research, Lightchain, Point72 Asset Management, RiverVest Venture Partners, and Roche Venture Fund

2

4/2/2021

Series B

Fervo Energy

$28M

Yes

Breakthrough Energy Ventures, Capricorn Investment Group, Congruent Ventures, and Elemental Excelerator

2

9/4/2020

Series D

Subscribe to see more

$99M

Subscribe to see more

10

6/30/2020

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/3/2021

4/27/2021

4/2/2021

9/4/2020

6/30/2020

Round

Series A

Series C

Series B

Series D

Seed VC

Company

Claros Technologies

Arch Oncology

Fervo Energy

Subscribe to see more

Subscribe to see more

Amount

$5.35M

$105M

$28M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

University of Minnesota Discovery Capital

Adage Capital Management, Avego Healthcare Capital, Broadfin Capital, Cowen, Eventide Asset Management, FMB Research, Lightchain, Point72 Asset Management, RiverVest Venture Partners, and Roche Venture Fund

Breakthrough Energy Ventures, Capricorn Investment Group, Congruent Ventures, and Elemental Excelerator

Sources

11

2

2

10

10

3x5 Partners Portfolio Exits

2 Portfolio Exits

3x5 Partners has 2 portfolio exits. Their latest portfolio exit was Amplyx Pharmaceuticals on April 28, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/28/2021

Acquired

8

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

4/28/2021

00/00/0000

Exit

Acquired

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

Acquirer

Subscribe to see more

Sources

8

10

3x5 Partners Fund History

1 Fund History

3x5 Partners has 1 fund, including 3x5 Partners Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/24/2020

3x5 Partners Fund III

$46.4M

3

Closing Date

9/24/2020

Fund

3x5 Partners Fund III

Fund Type

Status

Amount

$46.4M

Sources

3

3x5 Partners Team

4 Team Members

3x5 Partners has 4 team members, including current Managing Director, Tony Arnerich.

Name

Work History

Title

Status

Tony Arnerich

Managing Director

Current

Joe Biller

Managing Director

Current

Nicholas Walrod

Managing Director

Current

David Yeh

Managing Director

Current

Name

Tony Arnerich

Joe Biller

Nicholas Walrod

David Yeh

Work History

Title

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.